Back
Verrica Pharmaceuticals Vs. Exicure Industry Stock Comparison
Sell
47
VRCA
Verrica Pharmaceuticals
Last Price:
1.22
Seasonality Move:
50.53%
Buy
62
XCUR
Exicure
Last Price:
30.86
Seasonality Move:
-4.03%
Sell
47
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy, Sell or Hold?
- The current Verrica Pharmaceuticals [VRCA] share price is $1.24. The Score for VRCA is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- VRCA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Exicure (XCUR)
is a Buy
Is Exicure a Buy, Sell or Hold?
- The current Exicure [XCUR] share price is $31.99. The Score for XCUR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- XCUR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VRCA Stock Price Chart
What is Verrica Pharmaceuticals's stock price today?
-
The Verrica Pharmaceuticals share price today is $1.24
The current trend is relatively stagnant and VRCA is experiencing slight selling pressure.
XCUR Stock Price Chart
VRCA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 54.83 | Buy |
| Chaikin Money Flow: | -80935 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.8 - 1.42) | Buy |
| Bollinger Bands (100): | (0.6 - 5.4) | Sell |
XCUR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.9 | Buy |
| Relative Strength Index (14 RSI): | 95.88 | Buy |
| Chaikin Money Flow: | 80777 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (-1.39 - 16.11) | Buy |
| Bollinger Bands (100): | (-1.28 - 8.54) | Buy |
VRCA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1 | Buy |
| 20-day SMA: | 0.99 | Buy |
| 50-day SMA: | 1.31 | Sell |
| 200-day SMA: | 4.94 | Sell |
| 8-day EMA: | 1.04 | Buy |
| 20-day EMA: | 1.07 | Buy |
| 50-day EMA: | 1.57 | Sell |
| 200-day EMA: | 3.9 | Sell |
XCUR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.08 | Buy |
| 20-day SMA: | 8.58 | Buy |
| 50-day SMA: | 5.2 | Buy |
| 200-day SMA: | 3.1 | Buy |
| 8-day EMA: | 19.83 | Buy |
| 20-day EMA: | 11.91 | Buy |
| 50-day EMA: | 6.88 | Buy |
| 200-day EMA: | 3.97 | Buy |
Verrica Pharmaceuticals Earnings Growth & VRCA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and an increase next year of $0.82 per share.
Exicure Earnings Growth & XCUR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Verrica Pharmaceuticals Technical Analysis
| Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Exicure Technical Analysis
| Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||